Linea 2 – Neuroimmunopatologia e neuroinfiammazione

Visco C, Marchioni E, Pomponi F, Ferrante P, Delbue S, Pellizzer G, Rodeghiero F.Progressive multifocal leuconcephalopathy and autoimmune haemolytic anemia in chronic lymphocytic leukaemia: more than a fortuitous combination? Ann Hematol 2009; 88(2): 189-91

Bergamaschi R, Pichiecchio A, Persico A, Bastianello S. Relevance of clinical findings for diagnosis of neuromyelitis optica in MRI and NMO-IgG era. Eur J Neurol 2009; 16(4):e76-7

Bergamaschi R, Villani S, Crabbio M, Ponzio M, Romani A, Verri A, Bargiggia V, Cosi V. Inverse relationship between multiple sclerosis and allergic respiratory diseases. Neurol Sci 2009; 30(2):115-8

Ravaglia S, Bastianello S, Franciotta D, Ceroni M, Pichiecchio A, Tavazzi E,Marchioni E. NMO-IgG negative relapsing mielitis. Spinal Cord 2009; 47(7): 531-7

Ghezzi A, Amato MP, Annovazzi P, Capobianco M, Gallo P, La Mantia L, Marrosu MG, Martinelli V, Milani N, Moiola L, Patti F, Pozzilli C, Trojano M, Zaffaroni M, Comi G; ITEMS (Immunomodulatory Treatment of Early-onset MS) Group (in wich Bergamaschi R, Veggiotti P). Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experience. Neurol Sci 2009; 30(3):193-9

Ravaglia S, Tavazzi E, Moglia A, Ceroni M, Marchioni E. Combined central and peripheral demyelination: comparison of adult and pediatric series. Pediatr Neurol 2009; 41(1):77; author reply 77-8

Benvegnù S, Franciotta D, Sussman J, Bachi A, Zardini E, Torreri P, Govaerts C, Pizzo S, Legname G. Prion protein paralog doppel protein interacts with alpha-2-macroglobulin: a plausible mechanism for doppel-mediated neurodegeneration. PLoS One 2009; 4(6): e5968

Corato M, Ogliari P, Ceciliani F, Cova E, Bellotti V, Cereda C, Merlini M, Ceroni C.Doxorubicin and Congo Red Effectiveness on Prion Infectivity in Golden Syrian Hamster.Anticancer Res 2009; 29(7):2507-12

Patti F, Amato M, Trojano M, Bastianello S, Tola M, Goretti B, Caniatti L, Di Monte E, Ferrazza P, Brescia Morra V, Lo Fermo S, Picconi O, Luccichenti G. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. Mult Scler 2009; 15(7):779-88

Delbue S, Branchetti E, Bertolacci S, Tavazzi E, Marchioni E, Maserati R, Minnucci G, Tremolada S, Vago G, Ferrante P. JC virus VP1 loop-specific polymorphisms are associated with favorable prognosis for progressive multifocal leukoencephalopathy. J Neurovirol 2009; 15(1):51-6

Tumani H, Hartung HP, Hemmer B, Teunissen C, Deisenhammer F, Giovannoni G, Zettl UK; BioMS Study Group (in wich Franciotta D).Cerebrospinal fluid biomarkers in multiple sclerosis. Neurobiol Dis 2009; 35(2):117-27

Pichiecchio A, Tavazzi E, Maccabelli G, Ponzio M, Romani A, Schiappacassa R, Poloni GU, Franciotta D, Roccatagliata L, Bergamaschi R, Bastianello S. MR peri-CSF lesions and CSF oligoclonal bands in Italian multiple sclerosis patients. Acta Neurol Scand 2009; 120(4):242-5

Citterio A, Beghi E, Millul A, Evoli A, Mantegazza R, Antozzi C, Baggi F, Cornelio F, Durelli L, Clerico M, Piccolo G, Cosi V. Risk factors for tumor occurrence in patients with myasthenia gravis. J Neurol 2009; 256(8):1221-7

Portaccio E, Goretti B, Lori S, Zipoli V, Centorrino S, Ghezzi A, Patti F, Bianchi V, Comi G, Trojano M, Amato MP, Multiple Sclerosis Study Group of the Italian Neurological Society
(in wich Bergamaschi R, Veggiotti PA). The brief neuropsychological battery for children: a screening tool for cognitive impairment in childhood and juvenile multiple sclerosis. Mult Scler 2009; 15(5): 620-6

Trojano M, Pellegrini F, Paolicelli D, Fuiani A, Zimatore GB, Tortorella C, Simone IL, Patti F, Ghezzi A, Portaccio E, Rossi P, Pozzilli C, Salemi G, Lugaresi A, Bergamaschi R, Millefiorini E, Clerico M, Lus G, Vianello M, Avolio C, Cavalla P, Iaffaldano P, Direnzo V, D’Onghia M, Lepore V, Livrea P, Comi G, Amato MP. Post-marketing of disease modifying drugs in multiple sclerosis: An exploratory analysis of gender effect in interferon beta treatment. J Neurol Sci 2009; 286(1-2):109-113

Cortese A, Tavazzi E, Delbue S, Alfonsi E, Pichiecchio A, Ceroni M, Ferrante P,Marchioni E. Varicella Zoster virus-associated polyradiculoneuritis. Neurology 2009; 73 (16): 1334-5

Trojano M, Pellegrini F, Paolicelli D, Fuiani A, Zimatore GB, Tortorella C, Simone IL, Patti F, Ghezzi A, Zipoli V, Rossi P, Pozzilli C, Salemi G, Lugaresi A, Bergamaschi R, Millefiorini E, Clerico M, Lus G, Vianello M, Avolio C, Cavalla P, Lepore V, Livrea P, Comi G, Amato MP. Real-life impact of early interferonbeta therapy in relapsing multiple sclerosis. Ann Neurol 2009; 66(4):513-20

Bergamaschi R, Jarius S, Robotti M, Pichiecchio A, Wildemann B, Meola G. Two cases of benign neuromyelitis optica in patients with celiac disease. J Neurol 2009Aug 18. [Epub ahead of print]

Teunissen CE, Petzold A, Bennett JL, Berven FS, Brundin L, Comabella M, Franciotta D, Frederiksen JL, Fleming JO, Furlan R, Hintzen Md RQ, Hughes SG, Johnson MH, Krasulova E, Kuhle J, Magnone MC, Rajda C, Rejdak K, Schmidt HK, van Pesch V, Waubant E, Wolf C, Giovannoni G, Hemmer B, Tumani H, Deisenhammer F. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology 2009; 73(22):1914-22

Bergamaschi R, Montomoli C. Melanoma in multiple sclerosis treated with natalizumab: causal association or coincidence? Mult Scler 2009;15(12):1532-3

Bergamaschi R, Rezzani C, Minguzzi S, Amato MP, Patti F, Marrosu MG, Bonavita S, Grasso MG, Ghezzi A, Rottoli M, Gasperini C, Restivo D, Maimone D, Rossi P, Stromillo ML, Montomoli C, Solaro C, Group D. Validation of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis. Funct Neurol 2009; 24(3):159-62

Linea 3 – Processi neurodegenerativi e disordini del movimento

Blandini F, Bazzini E, Marino F, Saporiti F, Armentero MT, Pacchetti C, Zangaglia R, Martignoni E, Lecchini S, Nappi G, Cosentino M. Calcium Homeostasis Is Dysregulated in Parkinsonian Patients With l-DOPA-Induced Dyskinesias. Clin Neuropharmacol 2009; 32(3):133-9 

Terracciano A, Casali C, Grieco GS, Orteschi D, Di Giandomenico S, Seminara L, Di Fabio R, Carrozzo R, Simonati A, Stevanin G, Zollino M, Santorelli FM. An inherited large-scale rearrangement in SACS associated with spastic ataxia and hearing loss. Neurogenetics 2009; 10(2):151-5  

Pasqualetti P, Bonomini C, Dal Forno G, Paulon L, Sinforiani E, Marra C, Zanetti O, Rossini PM. A randomized controlled study on effects of ibuprofen on cognitive progression of Alzheimer’s disease. Aging Clin Exp Res 2009; 21(2):102-10  

Versino M, Franciotta D, Colnaghi S, Biagi F, Zardini E, Bianchi PI, Corazza GR, Cosi V. Cerebellar signs in celiac disease. Neurology 2009; 72(23):2046-8 

Manni R, Terzaghi M, Glorioso M. Motor-behavioral episodes in REM sleep behavior disorder and phasic events during REM sleep. Sleep 2009; 32 (2): 241-5 

Servello D, Sassi M, Bastianello S, Poloni GU, Mancini F, Pacchetti C. Electrode displacement after intracerebral hematoma as a complication of a deep brain stimulation procedure. Neuropsychiatr Dis Treat 2009 ;5: 183-7 

Zoccolella S, dell’Aquila C, Abruzzese G, Antonini A, Bonuccelli U, Canesi M, Cristina S, Marchese R, Pacchetti C, Zangaglia R, Logroscino G, Defazio G, Lamberti P, Livrea P.Hyperhomocysteinemia in levodopa-treated patients with Parkinson’s disease dementia. Mov Disord 2009; 24(7): 1028-33 

Zangaglia R, Pacchetti C, Pasotti C, Mancini F, Servello D, Sinforiani E, Cristina S, Sassi M, Nappi G. Deep brain stimulation and cognitive functions in Parkinson’s disease: A three-year controlled study. Mov Disord 2009; 24(11):1621-8  

Rombolà L, Corasaniti MT, Rotiroti D, Tassorelli C, Sakurada S, Bagetta G, Morrone LA.Effects of systemic administration of the essential oil of Bergamot (BEO) on gross behaviour and EEG power spectra recorded from the rat hippocampus and cerebral cortex. Funct Neurol 2009;  24(2): 107-12 

Guerini FR, Beghi E, Riboldazzi G, Zangaglia R, Pianezzola C, Bono G, Casali C, Di Lorenzo C, Agliardi C, Nappi G, Clerici M, Martignoni E. BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson’s disease. Eur J Neurol 2009; 16(11):1240-5 

Di Fonzo A, Fabrizio E, Thomas A, Fincati E, Marconi R, Tinazzi M, Breedveld GJ, Simons EJ, Chien HF, Ferreira JJ, Horstink MW, Abbruzzese G, Borroni B, Cossu G, Libera AD, Fabbrini G, Guidi M, De Mari M, Lopiano L, Martignoni E, Marini P, Onofrj M, Padovani A, Stocchi F, Toni V, Sampaio C, Barbosa ER, Meco G, The Italian Parkinson Genetics Network (in which  C. Tassorelli, C. Pacchetti, G. Nappi), Oostra BA, Bonifati V. GIGYF2 mutations are not a frequent cause of familial Parkinson’s disease. Parkinsonism Relat Disord 2009; 15(9):703-5 

Blandini F, Balestra B, Levandis G, Cervio M, Greco R, Tassorelli C, Colucci M, Faniglione M, Bazzini E, Nappi G, Clavenzani P, Vigneri S, De Giorgio R, Tonini M. Functional and neurochemical changes of the gastrointestinal tract in a rodent model of Parkinson’s disease. Neurosci Lett 2009; 31;467(3):203-7 

Sinforiani E, Zucchella C, Pasotti C, Bartolo M, Nappi G. Report of ten years’ activity in an Alzheimer’s disease assessment unit. Aging Clin Exp Res 2009; 21: 365-368

Linea 4 - Neurologia e psichiatria dello sviluppo

Orcesi S, La Piana R, Fazzi E. Aicardi-Goutieres syndrome. Br Med Bull 2009; 89: 183-201 

Brancati F, Iannicelli M, Travaglini L, Mazzotta A, Bertini E, Boltshauser E, D’Arrigo S, Emma F, Fazzi E, Gallizzi R, Gentile M, Loncarevic D, Mejaski-Bosnjak V, Pantaleoni C, Rigoli L, Salpietro CD, Signorini S, Stringini GR, Verloes A, Zabloka D, Dallapiccola B, Gleeson JG, Valente EM. MKS3/TMEM67 mutations are a major cause of COACH Syndrome, a Joubert syndrome related disorder with liver involvement. Hum Mutat 2009; 30(2):E432-42  

Kossoff EH, Zupec-Kania BA, Amark PE, Ballaban-Gil KR, Bergqvist AG, Blackford R, Buchhalter JR, Caraballo RH, Cross JH, Dahlin MG, Donner EJ, Klepper J, Jehle RS, Kim HD, Liu YM, Nation J, Nordli Jr DR, Pfeifer HH, Rho JM, Stafstrom CE, Thiele EA, Turner Z, Wirrell EC, Wheless JW, Veggiotti P, Vining EP. Optimal clinical management of children receiving the ketogenic diet: Recommendations of the International Ketogenic Diet Study Group. Epilepsia 2009; 50(2):304-17  

Mercuri E, Messina S, Bruno C, Mora M, Pegoraro E, Comi GP, D’Amico A, Aiello C, Biancheri R, Berardinelli A, Boffi P, Cassandrini D, Laverda A, Moggio M, Morandi L, Moroni I, Pane M, Pezzani R, Pichiecchio A, Pini A, Minetti C, Mongini T, Mottarelli E, Ricci E, Ruggieri A, Saredi S, Scuderi C, Tessa A, Toscano A, Tortorella G, Trevisan CP, Uggetti C, Vasco G, Santorelli FM, Bertini E. Congenital muscular dystrophies with defective glycosylation of dystroglycan. A population study. Neurology 2009; 72(21):1802-9 

Facchin P, Rosa-Rizzotto M, Turconi AC, Pagliano E, Fazzi E, Stortini M, Fedrizzi E, The Gipci Studi Group: Multisite trial on efficacy of constraint-induced movement. Multisite Trial on Efficacy of Constraint-Induced Movement Therapy in Children with Hemiplegia Study Design and Methodology therapy in children with hemiplegia: study design and methodology.Am J Phys Med Rehabil 2009; 88: 216-30 

Spinillo A, Montanari L, Gardella B, Roccio M, Stronati M, Fazzi E. Infant sex, obstetric risk factors, and 2-year neurodevelopmental outcome among preterm infants. Dev Med Child Neurol 2009; 51: 518-525 

Capovilla G, Striano P, Gambardella A, Beccaria F, Hirsch E, Casellato S, Romeo A, Rubboli G, Sofia V, Teutonico F, Valenti MP, Striano S. Eyelid fluttering, typical EEG pattern, and impaired intellectual function: A homogeneous epileptic condition among the patients presenting with eyelid myoclonia (p ). Epilepsia 2009; 50(6):1536-1541 

Ravaglia S, Moglia A, Costa A, Repetto A, Danesino C. Enzyme replacement therapy in late-onset type II glycogenosis (p ). Eur J Neurol 2009; 16(7): e125 

Ravaglia S, Moglia A, Bogdanov EI. Presyrinx in children with Chiari malformations.Neurology 2009; 72(22):1966-7  

Rice GI, Bond J, Asipu A, Brunette RL, Manfield IW, Carr IM, Fuller JC, Jackson RM, Lamb T, Briggs TA, Ali M, Gornall H, Couthard LR, Aeby A, Attard-Montalto SP, Bertini E, Bodemer C, Brockmann K, Brueton LA, Corry PC, Desguerre I, Fazzi E, Cazorla AG, Gener B, Hamel BC, Heiberg A, Hunter M, van der Knaap MS, Kumar R, Lagae L, Landrieu PG, Lourenco CM, Marom D, McDermott MF, van der Merwe W, Orcesi S, Prendiville JS, Rasmussen M, Shalev SA, Soler DM, Shinawi M, Spiegel R, Tan TY, Vanderver A, Wakeling EL, Wassmer E, Whittaker E, Lebon P, Stetson DB, Bonthron DT, Crow YJ. Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response. Nat Genet 2009;41(7):829-32  

Pichiecchio A, Poloni GU, Ravaglia S, Ponzio M, Germani G, Maranzana D, Costa A,Repetto A, Tavazzi E, Danesino C, Moglia A, Bastianello S. Enzyme replacement therapy in adult-onset glycogenosis II: Is quantitative muscle MRI helpful? Muscle Nerve 2009; 40(1): 122-5  

Mazzone ES, Messina S, Vasco G, Main M, Eagle M, D’Amico A, Doglio L, Politano L, Cavallaro F, Frosini S, Bello L, Magri F, Corlatti A, Zucchini E, Brancalion B, Rossi F, Ferretti M, Motta MG, Cecio MR, Berardinelli A, Alfieri P, Mongini T, Pini A, Astrea G, Battini R, Comi G, Pegoraro E, Morandi L, Pane M, Angelini C, Bruno C, Villanova M, Vita G, Donati MA, Bertini E, Mercuri E. Reliability of the North Star Ambulatory Assessment in a multicentric setting.Neuromuscul Disord 2009; 19 (7):458-61 

Bielas SL, Silhavy JL, Brancati F, Kisseleva MV, Al-Gazali L, Sztriha L, Bayoumi RA, Zaki MS, Abdel-Aleem A, Rosti RO, Kayserili H, Swistun D, Scott LC, Bertini E, Boltshauser E, Fazzi E, Travaglini L, Field SJ, Gayral S, Jacoby M, Schurmans S, Dallapiccola B, Majerus PW, Valente EM, Gleeson JG. Mutations in INPP5E, encoding inositol polyphosphate-5-phosphatase E, link phosphatidyl inositol signaling to the ciliopathies. Nat Genet 2009; 41(9):1032-6 

Izzotti A, Pulliero A, Orcesi Simona, Cartiglia C, Longobardi MG, Capra V, Lebon P, Cama A, La Piana R, Lanzi G, Fazzi E. Interferon-related transcriptome alterations in the cerebro spinal fluid cells of Aicardi-Goutières patients. Brain Pathology 2009; 19(4):650-60 

Balottin U, Rossi M, Rossi G, Viganò L, Nanti M, Salini S, Lanzi G, Termine C. The Rorschach test and Gilles de la Tourette’s syndrome: A pilot case-control study. Brain Dev 2009; 31(9):657-65 

Travaglini L, Brancati F, Attie-Bitach T, Audollent S, Bertini E, Kaplan J, Perrault I, […],Fazzi E, […] Signorini S, Uggetti C, […]. Expanding CEP290 mutational spectrum in ciliopathies. Am J Med Genet A 2009; 149A(10): 2173-80  

Tonin P, Bruno C, Cassandrini D, Savio C, Tavazzi E, Tomelleri G, Piccolo G. Unusual presentation of phosphoglycerate mutase deficiency due to two different mutations in PGAM-M gene. Neuromuscul Disord. 2009; 19(11):776-8  

Coccini T, Crevani A, Rossi G, Assandri F, Balottin U, Nardo RD, Manzo L. Reduced platelet monoamine oxidase type B activity and lymphocyte muscarinic receptor binding in unmedicated children with attention deficit hyperactivity disorder. Biomarkers 2009; 14(7):513-22 

Fazzi E, Bova S, Giovenzana A, Signorini S, Uggetti C, Bianchi P. Cognitive visual dysfunctions in preterm children with periventricular leukomalacia. Dev Med Child Neurol 2009; 51(12):974-81 

Uggetti C, La Piana R, Orcesi S, Egitto MG, Crow YJ, Fazzi E. Aicardi-Goutieres Syndrome: Neuroradiologic Findings and Follow-Up. AJNR Am J Neuroradiol 2009; 30(10):1971-6 

De Filippi P, Zecca M, Lisini D, Rosti V, Cagioni C, Carlo-Stella C, Radi O, Veggiotti P, Mastronuzzi A, Acquaviva A, D’Ambrosio A, Locatelli F, Danesino C. Germ-line mutation of the NRAS gene may be responsible for the development of juvenile myelomonocytic leukaemia.Br J Haematol 2009; 147(5):706-9 

Raucci U, Longhi R, Calmieri A, Osti M, Scateni S, Tozzi AE, Reale A, Rimini A, Giada F, Foglia Manzillo G, Francese GM, Ammirati F, Drago F, Semproni G, Campisi M, Rando F, Giordano U, Veggiotti P, Vigevano F, Di Capua M. La sincope in età pediatrica. Linee Guida a cura di SIP, SIMEUP, SICP, FMSI, AIAC SIC SPORT, FIMP, GSCP, GSMESPO, SINPIA, SINC.Minerva Pediatr ,2008 Oct;60(5):840-845

Balestri P, Longhi R, Franzoni E, Grosso S, Iannetti P, Pavone L, Verrotti A, Messi G, Palmieri A, Capovilla G, Mastrangelo M, Romeo A, Vigevano F, Coppola G, Dalla Bernardina B, Gobbi G, Parmeggiani A, Veggiotti P, Ballestrazzi A, Del Gobbo L, Bascelli E, Masiero G, Albani F, Bernardi B, Galluzzi P, De Martino M. La gestione del bambino con convulsioni febbrili: linee guida sulle convulsioni febbrili. Minerva Pediatr, 2008 Oct;60(5):836-839

Linea 5 – Neurologia funzionale e disordini dei comportamenti adattativi

Rondanelli M, Opizzi A, Solerte SB, Trotti R, Klersy C, Cazzola R. Administration of a dietary supplement (N-oleyl-phosphatidylethanolamine and epigallocatechin-3-gallate formula) enhances compliance with diet in healthy overweight subjects: a randomized controlled trial. BJN 2009; 101(3):457-64

Ghiotto N, Sances G, Galli F, Tassorelli C, Guaschino E, Sandrini G, Nappi G.Medication overuse headache and applicability of the ICHD-II diagnostic criteria: 1-year follow-up study (CARE I protocol).Cephalalgia 2009; 29(2):233-43

Colnaghi S, Versino M. Comments on: “Tolosa-Hunt syndrome: MR imaging features in 15 patients with 20 episodes of painful ophthalmoplegia” Eur J Radiol 2009; 69 (1):193

Rossi P, Faroni J, Tassorelli C, Nappi G. Diagnostic Delay and Suboptimal Management in a Referral Population With Hemicrania Continua. Headache 2009; 49(2): 227-34

Allena M, Katsarava Z, Nappi G. From drug-induced headache to medication overuse headache. A short epidemiological review, with a focus on Latin American countries. J Headache Pain 2009; 10(2):71-76

Nappi RE, Sances G, Detaddei S, Ornati A, Chiovato L, Polatti F. Hormonal management of migraine at menopause. Menopause International 2009; 15(2):82-6

Di Lorenzo C, Pierelli F, Coppola G, Grieco GS, Rengo C, Ciccolella M, Magis D, Bolla M, Casali C, Santorelli FM, Schoenen J. Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs. Neurology 2009; 72(18): 1588-94

D’Onofrio M, Ambrosini A, Di Mambro A, Arisi I, Santorelli FM, Grieco GS, Nicoletti F,Nappi G, Pierelli F, Schoenen J, Buzzi MG. The interplay of two single nucleotide polymorphisms in the CACNA1A gene may contribute to migraine susceptibility. Neurosci Lett 2009; 453(1): 12-5

Bagetta G, Sandrini G. The XX Ottorino Rossi Award. Funct Neurol 2009; 24(1):5-7

Rossi P, Schoenen J, Bolla M, Tassorelli C, Sandrini G, Nappi G. Implementation and evaluation of existing guidelines on the use of neurophysiological tests in non-acute migraine patients: a questionnaire survey of neurologists and primary care physicians. Eur J Neurol 2009; 16: 937-42

Di Lorenzo C, Di Lorenzo G, Sances G, Ghiotto N, Guaschino E, Grieco GS, Santorelli FM, Casali C, Troisi A, Siracusano A, Pierelli F. Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphism. J Headache Pain 2009; 10(5):349-55

Sances G, Guaschino E, Perucca P, Allena M, Ghiotto N, Manni R. Migralepsy: A call for a revision of the definition. Epilepsia 2009; 50(11):2487-96

Olesen J, Steiner T, Bousser MG, Diener HC, Dodick D, First MB, Goadsby PJ, Göbel H, Lainez MJ, Lipton RB, Nappi G, Sakai F, Schoenen J, Silberstein SD. Proposals for new standardized general diagnostic criteria for the secondary headaches. Cephalalgia 2009; 29(12):1331-6

Rossi P, Jensen R, Nappi G, Allena M. A narrative review on the management of medication overuse headache: the steep road from experience to evidence. J Headache Pain 2009; 10: 407-17

Allena M, Katsarava Z, Nappi G. Authors’ reply. J Headache Pain 2009 ; 10(6):479-80

Sandrini G, Perrotta A, Tassorelli C, Nappi G. Eletriptan. Expert Opin Drug Metab Toxicol 2009; 5(12): 1587-98

Nappi G, Milanesi PG. Innocent pain: the experience of pain in metaphysics, phenomenology and neurophilosophy. Funct Neurol 2009; 24(3):119-20

Linea 6 – Neuroscienze intervenzionali e metodologie innovative in riabilitazione

Di Bonaventura C, Bonini F, Fattouch J, Mari F, Petrucci S, Carnì M, Tinelli E, Pantano P,Bastianello S, Maraviglia B, Manfredi M, Prencipe M, Giallonardo AT. Diffusion-weighted magnetic resonance imaging in patients with partial status epilepticus. Epilepsia 2009; 50 Suppl 1:45-52  

Pichiecchio A, Tavazzi E, Maccabelli G, Precupanu C, Romani A, Roccatagliata L, Luccichenti G, Bergamaschi R, Bastianello S. What insights have new imaging techniques given into aggressive forms of MS – different forms of MS or different from MS? Mult Scler 2009; 15(3):285-93  

Rumboldt Z, Rowley HA, Steinberg F, Maldjian JA, Ruscalleda J, Gustafsson L, Bastianello S. Multicenter, double-blind, randomized, intra-individual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine in MRI of brain tumors at 3 tesla. J Magn Reson Imaging 2009; 29(4):760-7  

Roccatagliata L, Vuolo L, Bonzano L, Pichiecchio A, Mancardi GL. Multiple sclerosis: hyperintense dentate nucleus on unenhanced T1-weighted MR images is associated with the secondary progressive subtype. Radiology 2009; 251(2):503-10   

Bastianello S, Luccichenti G, Giugni E,  Pezzella FR, Calliada F. Splitting the technology: functional imaging between open and higt-field magnetic resonance. Funct Neurol 2009; 24 (2): 69-70 

Di Perri C, Dwyer MG, Wack DS, Cox JL, Hashmi K, Saluste E, Hussein S, Schirda C, Stosic M, Durfee J, Poloni GU, Nayyar N, Bergamaschi R, Zivadinov R. Signal abnormalities on 1.5 and 3 tesla brain MRI in multiple sclerosis patients and healthy controls. A morphological and spatial quantitative comparison study. Neuroimage 2009; 47(4):1352-62 

Tassorelli C, Buscone S, Sandrini G, Pacchetti C, Furnari A, Zangaglia R, Bartolo M, Nappi G, Martignoni E. The role of rehabilitation in deep brain stimulation of the subthalamic nucleus for Parkinson’s disease: A pilot study. Parkinsonism Relat Disord 2009; 15(9):675-681  

Bartolo M, Don R, Ranavolo A, Serrao M, Sandrini G. Kinematic and neurophysiological models: Future applications in neurorehabilitation. J Rehabil Med 2009; 41(12):986-7 

Linea 7 – Diagnostica e terapia delle sindormi epilettiche

Arzimanoglou A, French J, Blume WT, Cross JH, Ernst JP, Feucht M, Genton P, Guerrini R, Kluger G, Pellock JM, Perucca E, Wheless JW. Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol 2009; 8(1):82-93 

Perucca E, Tomson T. Epilepsy: seizures, syndromes, and survival.  Lancet Neurol 2009; 8(1):10-2  

Bialer M, Johannessen SI, Levy RH, Perucca E, Tomson T, White HS. Progress report on new antiepileptic drugs: A summary of the Ninth Eilat Conference (EILAT IX). Epilepsy Res 2009; 83(1):1-43 

Aguglia U, Barboni G, Battino D, Cavazzuti GB, Citernesi A, Corosu R, Guzzetta FM, Iannetti P, Mamoli D, Patella A, Pavone L, Perucca E, Primiero F, Pruna D, Savasta S, Specchio LM, Verrotti A. Italian consensus conference on epilepsy and pregnancy, labor and puerperium.Epilepsia 2009; 50 Suppl 1: 7-23 

Rusca A, Di Stefano AF, Doig MV, Scarsi C, Perucca E. Relative bioavailability and pharmacokinetics of two oral formulations of docosahexaenoic acid/eicosapentaenoic acid after multiple-dose administration in healthy volunteers. Eur J Clin Pharmacol 2009; 65(5):503-10 

Franciotta D, Kwan P, Perucca E. Genetic basis for idiosyncratic reactions to antiepileptic drugs. Curr Opin Neurol 2009; 22(2):144-9 

Galimberti CA, Magri F, Copello F, Arbasino C, Chytiris S, Casu M, Ameri P, Perucca P, Murialdo G. Changes in sex steroid levels in women with epilepsy on treatment: relationship with antiepileptic therapies and seizure frequency. Epilepsia 2009; 50 Suppl 1: 28-32  

Galimberti CA, Ossola M, Colnaghi S, Arbasino C. Focal epileptic seizures mimicking sleep paralysis. Epilepsy Behav 2009; 14 (3): 562-4  

Terzaghi M, Sartori I, Rustioni V, Manni R. Cyclic vomiting syndrome in adults: disregarding a possible epileptic component? Neurogastroenterol Motil 2009; 21(1): ,95-6 

Terzaghi M, Sartori I, Tassi L, Didato G, Rustioni V, LoRusso G, Manni R, Nobili L.Evidence of dissociated arousal states during NREM parasomnia from an intracerebral neurophysiological study. Sleep 2009; 32(3):409-12 

Curia G, Biagini G, Perucca E, Avoli M. Lacosamide: a new approach to target voltage-gated sodium currents in epileptic disorders. CNS Drugs 2009; 23(7): 555-68 

Perucca P, Carter J, Vahle V, Gilliam FG. Adverse antiepileptic drug effects: toward a clinically and neurobiologically relevant taxonomy. Neurology 2009; 72 (14): 1223-9  

Saetre E, Abdelnoor M, Amlie JP, Tossebro M, Perucca E, Taubøll E, Anfinsen OG, Isojärvi J, Gjerstad L. Cardiac function and antiepileptic drug treatment in the elderly: A comparison between lamotrigine and sustained-release carbamazepine. Epilepsia 2009; 50(8):1841-9 

The EURAP Study Group (Central project commission of EURAP: Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E, Sabers A, Vajda F, Tomson T).Utilization of antiepileptic drugs during pregnancy: Comparative patterns in 38 countries based on data from the EURAP registry (p ). Epilepsia 2009; 50(10): 2305-9 

Ramsay RE, Perucca E, Robbins J, Barrett JA, Spiegel K. Rapid onset of seizure suppression with pregabalin adjunctive treatment in patients with partial seizures. Epilepsia 2009; 50(8):1891-8 

Murialdo G, Magri F, Tamagno G, Ameri P, Camera A, Colnaghi S, Perucca P, Ravera G, Galimberti CA. Seizure frequency and sex steroids in women with partial epilepsy on antiepileptic therapy. Epilepsia 2009; 50(8):1920-6  

Wild JM, Chiron C, Ahn H, Baulac M, Bursztyn J, Gandolfo E, Goldberg I, Goñi FJ, Mercier F, Nordmann JP, Safran AB, Schiefer U, Perucca E. Visual field loss in patients with refractory partial epilepsy treated with vigabatrin: final results from an open-label, observational, multicentre study. CNS Drugs 2009; 23(11):965-82 

Battaglia D, Veggiotti P, Lettori D, Tamburrini G, Tartaglione T, Graziano A, Veredice C, Sacco A, Chieffo D, Pecoraro A, Colosimo C, Di Rocco C, Dravet C, Guzzetta F. Functional hemispherectomy in children with epilepsy and CSWS due to unilateral early brain injury including thalamus: Sudden recovery of CSWS. Epilepsy Res 2009; 87(2-3):290-8 

Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, Moshé SL,Perucca E, Wiebe S, French J. Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010; 51(6):1069-77

Perucca E. Extended-release formulations of antiepileptic drugs: rationale and comparative value. Epilepsy Curr 2009; 9(6):153-7 

Perucca E. What is the promise of new antiepileptic drugs in status epilepticus? Focus on brivaracetam, carisbamate, lacosamide, NS-1209, and topiramate. Epilepsia 2009; 50(Suppl 12): 49-50 

Linea 9 – L’apporto della genetica alla definizione dei fenotipi clinici: patologie mono e poligeniche

Zuffardi O, Bonaglia M, Ciccone R, Giorda R. Inverted duplications deletions: underdiagnosed rearrangements?? Clin Genet 2009; 75(6):505-13 

Clayton-Smith J, Walters S, Hobson E, Burkitt-Wright E, Smith R, Toutain A, Amiel J, Lyonnet S, Mansour S, Fitzpatrick D, Ciccone R, Ricca I, Zuffardi O, Donnai D. Xq28 duplication presenting with intestinal and bladder dysfunction and a distinctive facial appearance. Eur J Hum Genet 2009; 17(4):434-43 

Thauvin-Robinet C, Callier P, Franco B, Zuffardi O, Payet M, Aral B, Gigot N, Donzel A, Mosca-Boidron AL, Masurel-Paulet A, Huet F, Teyssier JR, Mugneret F, Faivre L. Search for genomic imbalances in a cohort of 20 patients with oral-facial-digital syndromes negative for mutations and large rearrangements in the OFD1 gene. Am J Med Genet A 2009; 149A(8):1846-9 

Bonaglia MC, Giorda R, Beri S, Bigoni S, Sensi A, Baroncini A, Capucci A, De Agostini C, Gwilliam R, Deloukas P, Dunham I, Zuffardi O. Mosaic 22q13 deletions: evidence for concurrent mosaic segmental isodisomy and gene conversion. Eur J Hum Genet 2009; 17(4): 426-33 

Carboni I, Andreucci E, Caruso MR, Ciccone R, Zuffardi O, Genuardi M, Pela I, Giglio S.Medullary sponge kidney associated with primary distal renal tubular acidosis and mutations of the H+-ATPase genes. Nephrol Dial Transplant 2009; 24(9):2734-8  

Giorda R, Bonaglia MC, Beri S, Fichera M, Novara F, Magini P, Urquhart J, Sharkey FH, Zucca C, Grasso R, Marelli S, Castiglia L, Di Benedetto D, Musumeci SA, Vitello GA, Failla P, Reitano S, Avola E, Bisulli F, Tinuper P, Mastrangelo M, Fiocchi I, Spaccini L, Torniero C, Fontana E, Lynch SA, Clayton-Smith J, Black G, Jonveaux P, Leheup B, Seri M, Romano C, dalla Bernardina B, Zuffardi O. Complex segmental duplications mediate a recurrent dup(X)(p11.22-p11.23) associated with mental retardation, speech delay, and EEG anomalies in males and females. Am J Hum Genet 2009; 85(3):394-400